Marker | PIK3CA wild type (n = 19) | PIK3CA mutant (n = 72) |  | P value |
---|---|---|---|---|
EGFR mean AS | 2.4 (2.6) | 3.8 (2.7) | Â | 0.043* |
EGFR HL AS | 12 | 23 | Â | 0.018 ** (ORÂ =Â 3.652) |
EGFR LL AS | 49 | 7 |
 | Lymph node negative (n = 65) | Lymph node positive (n = 21) |  |  |
---|---|---|---|---|
EGFR mean AS | 2.9 (2.5) | 1.7 (2.5) | Â | 0.047 |
EGFR HL AS | 26 | 4 | Â | 0.114* |
EGFR LL AS | 39 | 17 |
 | Well differentiated (n = 8) | Moderately differentiated (n = 67) | Poorly differentiated (n = 26) |  |
---|---|---|---|---|
EGFR mean AS | 4.3 (2.5) | 2.2 (2.5) | 3.4 (2.8) | 0.029 *** |
EGFR HL AS | 5 | 21 | 12 | 0.351a,* |
EGFR LL AS | 3 | 46 | 14 |
 | Lymph node negative (n = 65) | Lymph node positive (n = 21) |  |  |
---|---|---|---|---|
p-AKT cytoplasmic mean AS | 4.9 (2.3) | 5.8 (2.2) | Â | 0.027 * |
p-AKT cytoplasmic | ||||
 HL AS | 52 | 18 |  | 0.751** |
 LL AS | 13 | 3 |  |
 | Well differentiated (n = 8) | Moderately differentiated (n = 65/66) | Poorly differentiated (n = 27) |  |
---|---|---|---|---|
p-AKT cytoplasmic mean AS | 6.6 (0.5) | 5.4 (2.0) | 4.5 (2.3) | 0.009 *** |
p-AKT cytoplasmic | Â | Â | Â | 0.518a,* |
 HL AS | 8 | 56 | 22 |  |
 LL AS | 0 | 9 | 5 | |
p-AKT nuclear mean AS | 5.1 (3.1) | 3.3 (3.0) | 2.0 (2.7) | 0.014 *** |
p-AKT nuclear | Â | Â | Â | 0.178a,* |
 HL AS | 5 | 35 | 10 |  |
 LL AS | 3 | 31 | 17 |